Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06587698
NA

Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS

Sponsor: Peking University Third Hospital

View on ClinicalTrials.gov

Summary

This study will be carried out under the guidance of professional doctor, patients with PCOS will be treated with Sitagliptin or BeiDouGen capsule or both two to assess their ovarian function and reproductive outcomes, and compare the effect of different treatment methods, which will provide the basis for PCOS intervention strategy and related research

Key Details

Gender

FEMALE

Age Range

20 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

300

Start Date

2024-08-21

Completion Date

2029-07-01

Last Updated

2024-09-19

Healthy Volunteers

No

Interventions

DRUG

Sitagliptin

100 mg QD for 3 month

DRUG

BeiDouGen

60 mg BID for 3 month

DRUG

Sitagliptin+BeiDouGen

100 mg Sitagliptin QD plus BeiDouGen 60 mg BID for 3 month

Locations (1)

Peking University Third Hospital

Beijing, Beijing Municipality, China